Delivery Order SPE2DX22D0010-SPE2D825FFN68
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$4.7K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,064.00, is for the delivery of 4,567,948,312 tablets of 30mg Adderall, a medication used to treat ADHD. The contract has an ultimate completion date of April 18, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 20mg Adderall tablets, a medication used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $1,613.99 and runs through January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,263.86. It was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with the company that has a ceiling value of $999,999,999 and runs through November 2026. The delivery order is for 4,559,657,489 units of Adderall 10 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This contract does not have any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,394.18, is for the delivery of 4,568,294,064 units of Adderall 5 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2025. This delivery order is associated with Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 10 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,266.02 and is a firm fixed-price delivery order with a completion date of July 3, 2025. The contract is not set-aside and was awarded...
This federal contract award, valued at $9,318.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,831,561 tablets of Adderall 20 mg, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of January 3, 2025 and utilizes a firm fixed-price pricing structure. This contract does...
This federal contract award, valued at $1,266.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 10 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a total...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,949.18 contract is for the supply of Adderall 5 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a performance period extending through June 27, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a delivery order worth $3,506.94 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Adderall 10 mg tablets. The contract has a performance period that runs through August 20, 2024 and is a firm fixed-price type. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,511.41 firm fixed-price delivery order is for the supply of 4,568,262,795 tablets of 15 mg Adderall, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 16, 2025 and does not utilize a set-aside designation, indicating open...